Ohio takes legal action against pharma companies for opioid crisis
June 1, 2017Medical Communications Ohio, opioid, opioid crisis
If there is one state that needs answers for its citizens’ struggles with opioids, it is Ohio. The state saw …
Navigating the challenges of health technology assessment
May 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI, Global Pricing Innovations
In the face of restricted budgets, payers worldwide are increasingly using Health Technology Assessments (HTAs) as a way of managing …
NLS Pharma reveals data on different kind of ADHD treatment
May 31, 2017Research and Development NLS Pharma, mazindol
Most treatments for ADHD are stimulants, while the two most common treatments Adderall and Ritalin contain amphetamines. Due to the …
Collegium bring in former Biogen SVP as new COO
May 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Collegium pharmaceutical
Collegium Pharmaceutical has announced the appointment of Joseph Ciaffoni to the position of Executive Vice President and Chief Operating Officer. …
Could robots solve the pharma talent crisis?
May 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, UK, brexit, pharma, talent crisis
Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. …
FDA approves first generic versions of Lilly’s ADHD drug
May 31, 2017Research and Development, Sales and Marketing ADHD, Apotex, Aurobindo, FDA, Glenmark, Teva
The FDA has given its approval for the commercialisation of the first-ever generic versions of Eli Lilly’s Strattera (atomoxetine) for …
Evidence of tampering with Valium medication in Australia
May 31, 2017Medical Communications, Research and Development Roche, valium
Roche, the supplier of Valium in Australia, had notified the Therapeutic Goods Administration (TGA) that it had discovered evidence of …
Mounting US pricing pressures cutting into quarterly sales, Novartis admits
May 31, 2017Research and Development, Sales and Marketing Novartis, Sandoz
Novartis has revealed that increasing pressure on pricing in the US has impacted its second-quarter business, cutting into sales generated …
MSD allays Irish fears with €280m expansion investment
May 31, 2017Manufacturing and Production, Research and Development Ireland, MSD
There were fears in Ireland that President Trump’s strong words to bring manufacturing back to the US would hurt the …
Modified antibiotic shows big promise against drug-resistant bacteria
May 30, 2017Research and Development antibiotic resistance, vancomycin
Scientists at The Scripps Research Institute (TSRI) have succeeded in reengineering vancomycin – a widely-used antibiotic – in order to …
BMS and Array BioPharma partner up to tackle colorectal cancer
May 30, 2017Manufacturing and Production, Research and Development, Sales and Marketing Array Biopharma, BMS, Bristol-Myers Squibb
Bristol-Myers Squibb and Array BioPharma have announced they are to join forces as part of a new clinical research partnership …
Glenmark greenlighted to market hypertension generic in US
May 30, 2017Manufacturing and Production, Sales and Marketing FDA, Glenmark, generic, hypertension
Glenmark Pharmaceuticals has revealed it has been awarded final approval by the FDA to market hypertension treatment nebivolol, a generic …
Beta blockers offer little to no benefit for heart attack patients, study suggests
May 30, 2017Manufacturing and Production, Research and Development beta-blockers, heart attack
New research from the University of Leeds has called into question the prevalent practice of prescribing beta blockers for heart …
FDA approves Novartis’ Zykadia as first-line lung cancer treatment
May 30, 2017Manufacturing and Production, Sales and Marketing FDA, NSCLC, Novartis
The FDA has announced it has approved Novartis’ Zykadia (ceritinib) as a first line treatment in the expanded indication of …
Gene-editing tool CRISPR found to cause unintentional mutations in live animal models
May 30, 2017Manufacturing and Production, Research and Development crispr
Gene-editing has been heralded as a wonder tool which could lead to huge advances in a wide range of treatment …
Global Pricing Innovations and Pricing360 announce new strategic partnership
May 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
London, May 30, 2017 – Global Pricing Innovations (GPI), the pricing and intelligence experts for the life sciences industry and …
WHO elects first African Director General
May 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, appointment
Ethiopian-born Tedros Adhanom Ghebreyesus has been announced as the Next Director General of the World Health Organization (WHO) after securing …
Superbugs in the supply chain
May 26, 2017Medical Communications Antibiotics, Changing Markets, China, IMAGE: Changing Markets, Superbugs
Bad Manufacturing Practices: Changing Markets examines China’s role in the antibiotics supply chain and the damaging pollution that results from …
New FDA Commissioner reveals strategy to drive down drug prices
May 26, 2017Manufacturing and Production, Sales and Marketing FDA, Scott Gottlieb, Trump, pricing
Deregulation, faster access and cheaper drug prices very quickly became the rallying cry for the Trump administration in the life …
Furore over DNA testing company’s licensing of consumers’ data
May 26, 2017Medical Communications 23andME, Ancestry, DNA, DNA testing, genetic information
A company that assesses DNA is dealing with the repercussions of public outcry after a data protection lawyer highlighted a …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
